Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • KKR to infuse up to Rs...

    KKR to infuse up to Rs 300 crore in Baby Memorial Hospital in Kerala

    GarimaWritten by Garima Published On 2019-02-19T16:14:12+05:30  |  Updated On 19 Feb 2019 4:14 PM IST
    KKR to infuse up to Rs 300 crore in Baby Memorial Hospital in Kerala

    Baby Memorial Hospital is expected to use the funds provided by KKR to settle some debt and expand facilities besides financing some inorganic growth opportunities.


    Mumbai: The New York-based Private equity firm, KKR & Co LP has opted to infuse Rs 200 to 300 crore in Kerala-based Baby Memorial Hospital (BMH). BMH is expected to utilize the funds received to settle debts and augment facilities apart from financing some inorganic growth opportunities.


    Founded in 1987, BMH was a tribute to late KC Varghese (known as 'Baby'), father of Dr K G Alexander, the Chairman and Chief Physician of the hospital.


    In 2018, during the outbreak of Kerala Nipah virus, BMH was in the front line to combat the spread of the Nipah outbreak in the state that killed 15 and sparked panic.


    At the moment KKR, one of the world’s largest alternate asset managers has plans to support the group with further capital over time, to help the business in its inorganic initiatives as well, sources told a daily.


    Earlier Medical Dialogues had reported that KKR had been into advanced negotiations with Emami Group for a structured credit deal worth Rs 2,000 crore. The money provided would be used to repay the loans raised by promoters and to meet working capital requirements.


    Also Read: KKR to infuse Rs 2000 crore in Emami Group


    According to recent media reports, renowned south Indian actor Mohanlal who holds a significant minority stake in BMH, is said to be inscribing an agreement with KKR shortly and a formal announcement is expected in a couple of weeks.


    However, KKR declined to comment on the deal and KG Alexander, chairman and managing director of Baby Memorial Hospital, also said he would not like to comment at this particular juncture.


    “BMH is expected to use the funds to settle some debt and expand facilities besides financing some inorganic growth opportunities. This could be significant, considering the healthcare opportunities in northern Kerala,” one of the sources mentioned above told ET.


    Coincidently, Last week, six-year-old Ritul Sajeesh had his first birthday without his mother Lini Puthssery, India’s ‘hero’ nurse who died after being infected by Nipah virus from a family under her care.

    agreementBaby Memorial HospitalBMHcapitalcompaniesdebtEmamiEmami Groupequityexpand facilityhealth news in indiaHospital in indiahospital newsinfuse fundinvestment newsinvestment news in indiaKeralakerala epidemicKKRMohanlalNew York CityNipahNipah virusorganic initiativesettle debtsouth actor
    Source : With input

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok